Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1973 2
1974 1
1981 1
1984 1
1989 1
1990 1
1996 1
1998 1
1999 1
2000 1
2011 1
2012 1
2014 1
2015 1
2017 1
2019 2
2020 2
2022 2
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

24 results

Results by year

Filters applied: . Clear all
Page 1
Triple Inhaled Therapy at Two Glucocorticoid Doses in Moderate-to-Very-Severe COPD.
Rabe KF, Martinez FJ, Ferguson GT, Wang C, Singh D, Wedzicha JA, Trivedi R, St Rose E, Ballal S, McLaren J, Darken P, Aurivillius M, Reisner C, Dorinsky P; ETHOS Investigators. Rabe KF, et al. N Engl J Med. 2020 Jul 2;383(1):35-48. doi: 10.1056/NEJMoa1916046. Epub 2020 Jun 24. N Engl J Med. 2020. PMID: 32579807 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study.
Wechsler ME, Menzies-Gow A, Brightling CE, Kuna P, Korn S, Welte T, Griffiths JM, Sałapa K, Hellqvist Å, Almqvist G, Lal H, Kaur P, Skärby T, Colice G; SOURCE study group. Wechsler ME, et al. Lancet Respir Med. 2022 Jul;10(7):650-660. doi: 10.1016/S2213-2600(21)00537-3. Epub 2022 Mar 29. Lancet Respir Med. 2022. PMID: 35364018 Clinical Trial.
Communicating climate change and health to specific target groups.
Lehrer L, Hellmann L, Temme H, Otten L, Hübenthal J, Geiger M, Jenny MA, Betsch C. Lehrer L, et al. Among authors: temme h. J Health Monit. 2023 Nov 29;8(Suppl 6):36-56. doi: 10.25646/11773. eCollection 2023 Nov. J Health Monit. 2023. PMID: 38105792 Free PMC article.
Estrone degradation: does organic matter (quality), matter?
Tan DT, Temme HR, Arnold WA, Novak PJ. Tan DT, et al. Among authors: temme hr. Environ Sci Technol. 2015 Jan 6;49(1):498-503. doi: 10.1021/es504424v. Epub 2014 Dec 11. Environ Sci Technol. 2015. PMID: 25454582
Enzyme catalytic concentrations in human plasma after a marathon.
Soeder G, Golf SW, Graef V, Temme H, Brüstle A, Róka L, Bertschat F, Ibe K. Soeder G, et al. Among authors: temme h. Clin Biochem. 1989 Apr;22(2):155-9. doi: 10.1016/s0009-9120(89)80015-3. Clin Biochem. 1989. PMID: 2470533
24 results